Currently out of the existing stock ratings of Saravana Raghavan, 6 are a HOLD (75%), 2 are a BUY (25%).

Saravana Raghavan

Work Performance Price Targets & Ratings Chart

Analyst Saravana Raghavan, currently employed at WELLS FARGO, carries an average stock price target met ratio of 100% that have a potential upside of 14.56% achieved within 296 days.

Saravana Raghavan’s has documented 17 price targets and ratings displayed on 2 stocks. The coverage is on Industrials, Technology sectors.

Most recent stock forecast was given on LII, Lennox International at 02-Feb-2022.

Wall Street Analyst Saravana Raghavan

Analyst best performing recommendations are on LII (LENNOX INTERNATIONAL).
The best stock recommendation documented was for LII (LENNOX INTERNATIONAL) at 7/21/2020. The price target of $255 was fulfilled within 8 days with a profit of $18.25 (7.71%) receiving and performance score of 9.64.

Average potential price target upside

LII Lennox International APH Amphenol

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Sep-2026

$424

$67.7 (19.00%)

$541

12 days ago
(25-Sep-2026)

15/19 (78.95%)

$50.23 (13.44%)

121

Buy Since 10-Dec-2021

$444

$87.7 (24.61%)

23 days ago
(14-Sep-2026)

20/21 (95.24%)

$78.49 (21.47%)

311

Sell Since 24-Apr-2025

$375

$18.7 (5.25%)

$450

1 months 4 days ago
(03-Sep-2026)

7/7 (100%)

$-11.08 (-2.87%)

55

Buy Since 10-Oct-2023

$547

$190.7 (53.52%)

$615

2 months 6 days ago
(31-Jul-2026)

9/12 (75%)

$131.12 (31.53%)

56

Hold Since 16-Aug-2023

$469

$112.7 (31.63%)

$579

2 months 7 days ago
(30-Jul-2026)

14/17 (82.35%)

$51.55 (12.35%)

45

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Saravana Raghavan?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?